Events

Field Safety Notices about IMMULITE 2000/2000 XPi Erythropoietin and IMMULITE 2500 Erythropoietin

According to Bundesinstitut für Arzneimittel und Medizinprodukte, this field safety notices involved a device in Germany that was produced by Siemens.

What is this?

Field safety notices are communications sent out by medical device manufacturers or their representatives in relation to actions that they may be taking in relation to their product that is on the market. These are mainly for health workers, but also for users. They can include recalls and alerts.

Learn more about the data here
  • Type of Event
    Field Safety Notice
  • Event ID
    03181/12
  • Date
    2012-05-30
  • Event Country
    Germany
  • Event Source
    BAM
  • Event Source URL
    https://www.bfarm.de/SharedDocs/Kundeninfos/EN/08/2012/03181-12_kundeninfo_en.html
  • Notes / Alerts
    German data is current through October 2018. All of the data comes from Bundesinstitut für Arzneimittel und Medizinprodukte, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Germany.
  • Extra notes in the data

Device

IMMULITE 2000/2000 XPi Erythropoietin and IMMULITE 2500 Erythropoietin
  • Model / Serial
  • Product Description
    In-vitro diagnostics - immunological products
  • Manufacturer
    Siemens

Manufacturer

Siemens
  • Source
    BAM